1471-0528/asset/BJO_left.gif?v=1&s=0fb87361cdb6be25fdf05019eed6d47f5143f610)
1471-0528/asset/olbannerright.gif?v=1&s=3892ef16ff18d6834c302faf85268a49f5fc588f)
Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia
Article first published online: 22 AUG 2005
DOI: 10.1111/j.1471-0528.1990.tb16240.x
Issue
1471-0528/asset/cover.gif?v=1&s=b4e1d96c46e18c61210d584b63c13ee375cf562b "BJOG: An International Journal of Obstetrics & Gynaecology")
BJOG: An International Journal of Obstetrics & Gynaecology
Volume 97, Issue 8, pages 690–694, August 1990
Additional Information
How to Cite
ANDERSSON, J. K. and RYBO, G. (1990), Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. BJOG: An International Journal of Obstetrics & Gynaecology, 97: 690–694. doi: 10.1111/j.1471-0528.1990.tb16240.x
Publication History
- Issue published online: 22 AUG 2005
- Article first published online: 22 AUG 2005
- Received 23 October 1989 Accepted 20 March 1990
- Abstract
- References
- Cited By
Summary. In 20 women with menorrhagia (>80 ml blood loss per menstrual period) a levonorgestrel-releasing intrauterine device (Lng-IUCD) was inserted. Menstrual blood loss (MBL) was measured in two consecutive cycles before the device was inserted and after 3, 6 and 12 months of use. MBL was significantly reduced after 3 months (86%) and after 12 months the reduction was 97%. There was a significant increase (P< 0.001) in serum ferritin during the first year of Lng-IUCD use. The Lng-IUCD seems to be an important alternative to oral medication and to hysterectomy in the treatment of menorrhagia.